{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:49:27Z","timestamp":1761058167448},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf00663009","type":"journal-article","created":{"date-parts":[[2004,11,30]],"date-time":"2004-11-30T10:52:11Z","timestamp":1101811931000},"page":"1-9","source":"Crossref","is-referenced-by-count":25,"title":["Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy"],"prefix":"10.1007","volume":"72","author":[{"given":"C.","family":"Bokemeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"K\ufffdhne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kynast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. -J.","family":"Schmoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198809083191001","volume":"319","author":"KS Amman","year":"1988","unstructured":"Amman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frei E, Schnipper LE (1988) Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med 319:593?598","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1200\/JCO.1995.13.1.79","volume":"13","author":"DF Bajorin","year":"1995","unstructured":"Bajorin DF, Nichols CR, Schmoll HJ, Kantoff PW, Bokemeyer C, Demetri GD, Einhorn LH, Bosl GJ (1995) Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial. J Clin Oncol 13:79?86","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"CR3","first-page":"45","volume":"14","author":"J Beyer","year":"1994","unstructured":"Beyer J, Schwella N, Strohscheer I, Schwander I, Zingsem J, Serke S, Huhn D, Siegert W (1994) Randomized comparison of hematopoietic rescue with stem\/progenitor cells from bone marrow or peripheral blood after high-dose chemotherapy in germ cell tumors. Bone Marrow Transplant 14 [Suppl 1]: 45","journal-title":"Bone Marrow Transplant"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.1986.4.3.400","volume":"4","author":"R Birch","year":"1986","unstructured":"Birch R, Williams S, Cone A, Einhorn LH, Roark P, Turner S, Greco FA (1986) Prognostic factors for favourable outcome in disseminated germ cell tumours. J Clin Oncol 4:400?407","journal-title":"J Clin Oncol"},{"key":"CR5","first-page":"234","volume":"13","author":"C Blanke","year":"1994","unstructured":"Blanke C, Loehrer PJ, Einhorn LH, Nichols C (1994) A phase-II study of VP-16 plus ifosfamide plus cisplatin plus vinblastine plus bleomycin (VIP\/VB) with filgrastim for advanced stage testicular cancer. Proc Am Soc Clin Oncol 13:234","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR6","first-page":"77","volume":"3","author":"C Bokemeyer","year":"1993","unstructured":"Bokemeyer C, Schmoll HJ, Casper J, Kuczyk M, Poliwoda H (1993) No growth stimulation of heterotransplanted human testicular cancer cell lines by recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF). Int J Oncol 3:77?80","journal-title":"Int J Oncol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0959-8049(05)80441-1","volume":"29A","author":"C Bokemeyer","year":"1993","unstructured":"Bokemeyer C, Schmoll HJ, Harstrick A (1993) Side effects of GM-CSF in advanced testicular cancer. Eur J Cancer 29A:924 (letter)","journal-title":"Eur J Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/0959-8049(93)90211-W","volume":"29A","author":"C Bokemeyer","year":"1993","unstructured":"Bokemeyer C, Schmoll HJ, Harstrick A, Illiger HJ, Metzner B, R\u00e4th U, Hohnloser J, Clemm C, Berdel W, Siegert W, Ruther U, Ostermann H, Kneba M, Hartlapp JH, Schr\u00f6der M, Poliwoda H (1993) A phase-1\/11 study of a stepwise doseescalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GMCSF) in patients with advanced germ cell tumours. Eur J Cancer 29A:2225?2231","journal-title":"Eur J Cancer"},{"key":"CR9","first-page":"671","volume":"4","author":"C Bokemeyer","year":"1994","unstructured":"Bokemeyer C, Beyer J, Schmoll HJ (1994) The role of doseintensified chemotherapy for the treatment of metastatic germ cell tumours. Forum 4:671?680","journal-title":"Forum"},{"key":"CR10","first-page":"236","volume":"13","author":"C Bokemeyer","year":"1994","unstructured":"Bokemeyer C, Schmoll HJ, Arseniev L, Metzner B, Ruther U, Illiger HJ, Link H, Poliwoda H (1994) Treatment of advanced testicular cancer with dose intensified chemotherapy plus GM-CSF alone or G-CSF and sequential harvesting and reinfusion of peripheral blood stem cells (PBSC). Proc Am Soc Clin Oncol 13:236","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR11","first-page":"596","volume":"14","author":"C Bokemeyer","year":"1995","unstructured":"Bokemeyer C, Harstrick A, Ruther U, Metzner B, Arseniev L, Kadar J, Illiger HJ, Link H, Raichele A, Beyer J, Hossfeld DK, Schmoll HJ (1995) Sequential treatment with high-dose VIP-chemotherapy plus peripheral blood stem cell (PBSC) support in advanced germ cell cancer. Proc Am Soc Clin Oncol 14:596","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0959-8049(94)90099-X","volume":"30A","author":"MA Boogaerts","year":"1994","unstructured":"Boogaerts MA (1994) Growth factors in hematology: prophylactic versus interventional use. Eur J Cancer 30A: 238?243","journal-title":"Eur J Cancer"},{"key":"CR13","first-page":"3403","volume":"43","author":"GJ Bosl","year":"1983","unstructured":"Bosl GJ, Geller N, Cirrincone C, Vogelzang NJ, Kennedy BJ, Whitmore WF, Vugrin D, Scher H, Nisselbaum J, Golbey RB (1983) Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 43:3403?3407","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood.V79.5.1193.1193","volume":"79","author":"W Brugger","year":"1992","unstructured":"Brugger W, Bross K, Frisch J, Lindemann A, Kanz L, Mertelsmann R (1992) Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony stimulating factor following polychemotherapy with etoposide, ifosfamide and cisplatin. Blood 79:1193?1200","journal-title":"Blood"},{"key":"CR15","first-page":"197","volume-title":"Hodentumoren ? testis cancer","author":"H Buzello","year":"1995","unstructured":"Buzello H (1995) Effect of granulocyte colony stimulating factor (G-CSF) on growth of testicular cancer cells in vitro. In: Schnorr D, Loenig SA, Wei\\bach L (eds) Hodentumoren ? testis cancer, Blackwell Wissenschaftsverlag, Berlin, pp 197?198"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1349-7006.1991.tb01779.x","volume":"82","author":"G Cimoli","year":"1991","unstructured":"Cimoli G, Russo P, Billi G, Nariani GL, Rovini E, Venturini M (1991) Human granulocyte-macrophage colony-stimulating factor, a growth factor active on human ovarian cancer cells. Jpn J Cancer Res 82:1196?1198","journal-title":"Jpn J Cancer Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/oxfordjournals.annonc.a058178","volume":"3","author":"G Daugaard","year":"1992","unstructured":"Daugaard G, Roerth M (1992) Treatment of poor-risk germcell tumors with high-dose cisplatin and etoposide combined with bleomycin. Ann Oncol 3:277?282","journal-title":"Ann Oncol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0959-8049(05)80032-2","volume":"30A","author":"E Diaz-Rubio","year":"1994","unstructured":"Diaz-Rubio E, Adrover E (1994) Use of granulocyte growth factors in solid tumours. Eur J Cancer 30A: 120?122","journal-title":"Eur J Cancer"},{"issue":"Suppl 8","key":"CR19","first-page":"38","volume":"5","author":"T Dunn","year":"1994","unstructured":"Dunn T, Bokemeyer C, Hartmann K, Rie C, Schmoll HJ (1994) Effect of hematopoietic growth factors (HGFs) on the growth of human embryonic carcinoma cell lines in reduced or serum free culture. Ann Oncol 5 [Suppl 8]: 38","journal-title":"Ann Oncol"},{"key":"CR20","first-page":"1777","volume":"11","author":"LH Einborn","year":"1990","unstructured":"Einborn LH (1990) Treatment of testicular cancer: a new improved model. J Clin Oncol 11:1777?1781","journal-title":"J Clin Oncol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.1989.7.3.387","volume":"7","author":"LH Einhorn","year":"1989","unstructured":"Einhorn LH, Williams SD, Loehrer PJ, Birch R, Drasga R, Omura G, Greco FA (1989) Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group Protocol. J Clin Oncol 7:387?391","journal-title":"J Clin Oncol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1200\/JCO.1990.8.1.170","volume":"8","author":"AD Elias","year":"1990","unstructured":"Elias AD, Eder JP, Shea T, Begg CB, Frei E, Antman KH (1990) High-dose ifosfamide with mesna uroprotection. J Clin Oncol 8:170?178","journal-title":"J Clin Oncol"},{"key":"CR23","first-page":"656","volume":"14","author":"S Fossa","year":"1995","unstructured":"Fossa S, Kaye SB, Cullen M, De Wit R, Bodrogi I, van Groeningen C, Sylvester R, Stenning S, Kaye SB, Cullen M, De Wit R, Lallemand E, Mead GM (1995) An MRC\/EORTC randomized trial in poor-prognosis metastatic teratoma, comparing treatment with\/without filgrastim. Proc Am Soc Clin Oncol 14:656","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.annonc.a057904","volume":"2","author":"A Harstrick","year":"1991","unstructured":"Harstrick A, Schmoll HJ, Kohne-Wompner CH, Bergamnn L, Lammers U, Hohnloser J, D\u00f6lken G, Reichhardt P, Siegert W, Natt F, R\u00e4th U, Wilke H, Poliwoda H (1991) Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma. Ann Oncol 2:197?202","journal-title":"Ann Oncol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1200\/JCO.1991.9.9.1549","volume":"9","author":"A Harstrick","year":"1991","unstructured":"Harstrick A, Schmoll HJ, Wilke H, Kohne-Wompner CH, Stahl M, Sch\u00f6ber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C, Bergmann L, Lammers U, Freund M, Poliwoda H (1991) Cisplatin, etoposide and ifosfamide salvage therapy for refractory or relapsed germ cell carcinoma. J Clin Oncol 9:1549?1555","journal-title":"J Clin Oncol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0959-8049(92)90392-F","volume":"28A","author":"DJ Husband","year":"1992","unstructured":"Husband DJ, Green JA (1992) POMB\/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity. Eur J Cancer 28A: 86?91","journal-title":"Eur J Cancer"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/oxfordjournals.annonc.a057799","volume":"1","author":"LM Jost","year":"1990","unstructured":"Jost LM, Pichert G, Stahel RA (1990) Placebo controlled phase-I\/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy. Ann Oncol 1:439?442","journal-title":"Ann Oncol"},{"issue":"Suppl I","key":"CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000421-199112001-00006","volume":"14","author":"L Kanz","year":"1991","unstructured":"Kanz L, Lindemann A, Oster W, Herrmann F, Mertelsmann R (1991) Hemopoietins in clinical oncology. J Clin Oncol 14 [Suppl I]: 27?33","journal-title":"J Clin Oncol"},{"key":"CR29","doi-asserted-by":"crossref","unstructured":"Levi JA, Toner G (1993) Dose intensive chemotherapy for poor prognosis germ cell malignancies. International Germ Cell Tumour Conference, Leeds, England","DOI":"10.1016\/B978-0-08-042198-8.50064-9"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.annonc.a057906","volume":"2","author":"CR Lewis","year":"1991","unstructured":"Lewis CR, Fossa SD, Mead G, Ten Bokkel Huinik W, Harding MJ, Mill L, Paul J, Jones WG, Rodenburg CJ, Cantwell B (1991) BOP\/VIP ? a new platinum-intensive chemotherapy regimen for poor prognosis germ cell tumours. Ann Oncol 2:203?211","journal-title":"Ann Oncol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJM199207023270106","volume":"327","author":"GJ Lieschke","year":"1992","unstructured":"Lieschke GJ, Burgess AW (1992) Granulocyte-colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28?35","journal-title":"N Engl J Med"},{"key":"CR32","first-page":"196","volume":"11","author":"W Linkesch","year":"1992","unstructured":"Linkesch W, Krainer M, Wagner A (1992) Phase I\/I1 trial of ultrahigh carboplatin, etoposide, cyclophosphamide with ABMT in refractory or relapsed non-seminomatous germ cell tumors (NSGCT). Proc Am Soc Clin Oncol 11:196","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1200\/JCO.1986.4.4.528","volume":"4","author":"PJ Loehrer","year":"1986","unstructured":"Loehrer PJ, Einhorn LH, Williams SD (1986) VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol 4:528?536","journal-title":"J Clin Oncol"},{"key":"CR34","first-page":"831","volume":"12","author":"PJ Loehrer","year":"1993","unstructured":"Loehrer PJ, Einhorn LH, Elson P, Williams SD, Havlin K, Vogelzang NJ, Crawford ED, Trump DL (1993) Phase-III study of cisplatin plus etoposide (VP16) with either bleomycin (B) or ifosfamide (1) in advanced-stage germ cell tumours (GCT): an Intergroup trial. Proc Am Soc Clin Oncol 12:831","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1200\/JCO.1985.3.3.326","volume":"3","author":"CJ Logothetis","year":"1985","unstructured":"Logothetis CJ, Samuels ML, Selig D, Swanson D, Johnson DE (1985) Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis. J Clin Oncol 3:326?335","journal-title":"J Clin Oncol"},{"key":"CR36","first-page":"97","volume":"13","author":"J Lynch","year":"1994","unstructured":"Lynch J, Lee R, Gross M, Vellis K, Hutchenson C, Ayash L, Weiner R, Moreb J (1994) Time to myeloid recovery is related to number of peripheral blood (PB) progenitors infused after high-dose chemotherapy. Proc Am Sac Clin Oncol 13:97","journal-title":"Proc Am Sac Clin Oncol"},{"key":"CR37","first-page":"240","volume":"12","author":"RA Mandanas","year":"1993","unstructured":"Mandanas RA, Broun ER, Nichols CR, Salzman D, Turns M, Einhorn LH (1993) Phase-I\/II dose-escalation study of carboplatin (CBDCA) and etoposide (VP-16) with autologous marrow support done in tandem for refractory germ cell tumors (GCT). Proc Am Soc Clin Oncol 12:240","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR38","first-page":"8","volume":"1","author":"Medical Research Council Working Party on Testicular Tumours","year":"1985","unstructured":"Medical Research Council Working Party on Testicular Tumours (1985) Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicenter study. Lancet 1:8?11","journal-title":"Lancet"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jcp.1041430312","volume":"143","author":"K Miyagawa","year":"1990","unstructured":"Miyagawa K, Chiba S, Shibuya K, Piao YF, Matsuki S, Yokota J, Terada M, Miyazono K, Takaku F (1990) Frequent expression of receptors for granulocyte-macrophage colony stimulating factor on nonhematopoietic tumour cell lines. J Cell Physiol 143:483?487","journal-title":"J Cell Physiol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/jnci\/84.22.1703","volume":"84","author":"RJ Motzer","year":"1992","unstructured":"Motzer RJ, Bosl GJ (1992) High-dose chemotherapy for resistant germ cell tumors: recent advances and future directions. J Natl Cancer Inst 84:1703?1709","journal-title":"J Natl Cancer Inst"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/1097-0142(19900901)66:5<857::AID-CNCR2820660508>3.0.CO;2-G","volume":"66","author":"RJ Motzer","year":"1990","unstructured":"Motzer RJ, Geller NL, Bosl GJ (1990) The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients. Cancer 66:857?861","journal-title":"Cancer"},{"key":"CR42","first-page":"206","volume":"19","author":"RJ Motzer","year":"1992","unstructured":"Motzer RJ, Bajorin DF, Bost GJ (1992) ?Poor risk? germ cell tumours: current progress and future directions. Semin Oncol 19:206?214","journal-title":"Semin Oncol"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/1097-0142(19920115)69:2<550::AID-CNCR2820690245>3.0.CO;2-D","volume":"69","author":"RJ Motzer","year":"1992","unstructured":"Motzer RJ, Gulati SC, Crown JP, Weisen S, Doherty M, Herr H, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ (1992) High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Cancer 69:550?556","journal-title":"Cancer"},{"key":"CR44","first-page":"233","volume":"12","author":"RJ Motzer","year":"1993","unstructured":"Motzer RJ, Gulati SC, Mazumdar M, Bajorin DF, Vlamis V, Lyn P, Bost GJ (1993) Phase-II trial of VAB-6+ high-dose carboplatin + etoposide (HD C+E) with autologous bone marrow transplantation (AUBMT) for poor-risk germ cell tumor (GCT) patients (PTS). Proc Am Soc Clin Oncol 12:233","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/jnci\/85.22.1828","volume":"85","author":"RJ Motzer","year":"1993","unstructured":"Motzer RJ, Mazumdar M, Subhash CG, Bajorin DF, Lyn P, Vlamis V, Bost GJ (1993) Phase-II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Natl Cancer Inst 85:1828?1835","journal-title":"J Natl Cancer Inst"},{"key":"CR46","first-page":"721","volume":"12","author":"BA Murphy","year":"1993","unstructured":"Murphy BA, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Currie V, Bosl GJ (1993) An analysis of the effect of dose intensity on response, event-free survival and overall survival in patients with germ cell tumours (GCT) receiving ifosfamide-based salvage therapy. Proc Am Soc Clin Oncol 12:721","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR47","first-page":"571","volume":"85","author":"S Nakagawa","year":"1994","unstructured":"Nakagawa S, Sugimoto K, Mikamie K, Watanabe H, Sonoda Y, Kuzuyama Y, Abe T, Fuji H (1994) Successful collection of peripheral blood stem cells mobilized by high-dose etoposide for patients with chemotherapy-resistant and\/or poor prognostic testicular cancer. Nippon Hinyokika Gakkai Zasshi 85:571?578","journal-title":"Nippon Hinyokika Gakkai Zasshi"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJM199005173222004","volume":"322","author":"CR Nichols","year":"1990","unstructured":"Nichols CR, Roth BJ, Heerema N, Griep J, Tricot G (1990) Hematologic neoplasia associated with primary mediastinal germ cell tumours. N Engl J Med 322:1425?1429","journal-title":"N Engl J Med"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1991.9.7.1163","volume":"9","author":"CR Nichols","year":"1991","unstructured":"Nichols CR, Williams SD, Loehrer PJ, Greco FA, Crawford ED, Weetlaufer J, Miller ME, Bartolucci A, Schacter L, Einhorn LH (1991) Randomized study of cisplatin dose intensity in poor risk germ cell tumours: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 9:1163?1172","journal-title":"J Clin Oncol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000474574","volume":"23","author":"S Roach","year":"1993","unstructured":"Roach S, Cooper S, Bennet W, Pera MF (1993) Cultured cell lines from human teratomas: windows into tumor growth and differentiation and early human development. Eur Urol 23:82?88","journal-title":"Eur Urol"},{"key":"CR51","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/oxfordjournals.annonc.a058111","volume":"3","author":"S Rodenhuis","year":"1992","unstructured":"Rodenhuis S, Baars JW, Schornagel JH, Vlasveld LT, Mandjes I, Pinedo HM, Richel DJ (1992) Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa. Ann Oncol 3:855?860","journal-title":"Ann Oncol"},{"key":"CR52","first-page":"248","volume":"13","author":"S Rodenhuis","year":"1994","unstructured":"Rodenhuis S, van der Wall E, Schornagel JH, Holtkamp M, Nooijen WJ, Baars JW (1994) Development of a multiple high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa and carboplatin with peripheral stem cell transplantation (PSCT). Proc Am Soc Clin Oncol 13:248","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2605.1987.tb00198.x","volume":"10","author":"HJ Schmoll","year":"1987","unstructured":"Schmoll HJ, Schubert I, Arnold H, D\u00f6lken G, Hecht T, Bergmann L, Illiger J, Fink U, Preiss J, Pfreundschuh M, Kaulen H, Bonfert B, Ho AD, Manegold C, Mayr A, Hoffmann L, Weiss J, Hecker H (1987) Disseminated testicular cancer with bulky disease: results of a phase-11 study with cisplatin ultra high dose\/VP-16\/bleomycin. Int J Androl 10:311?317","journal-title":"Int J Androl"},{"key":"CR54","first-page":"255","volume":"35","author":"J Sehrt","year":"1994","unstructured":"Sehrt J, Pietsch T, Sch\u00f6ffski P, Bokemeyer C, Kuczyk MA, Schmoll HJ, Jonas U (1994)A possible role for stem cell factor (SCF) and its receptor C-kit in malignant germ cell tumors. Proc Am Assoc Cancer Res 35:255","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.1994.12.6.1223","volume":"12","author":"W Siegert","year":"1994","unstructured":"Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D (1994) High-dose treatment with carboplatin, etoposide and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase-I\/II study. J Clin Oncol 12:1223?1231","journal-title":"J Clin Oncol"},{"key":"CR56","first-page":"465","volume":"13","author":"P Sobrevilla-Calvo","year":"1994","unstructured":"Sobrevilla-Calvo P, Zinser JW, Lara FU, Acosta-Barreda A, Guarner-Lans J, Miranda-Lopez E, Reynoso-Gomez E (1994) High-dose ICE (ifosfamide (I), carboplatin (C) and etoposide (E)) regimen supported with autologous transplantation of refrigerated peripheral blood stem cells (PAPBSC), mobilized with G-CSF: description of a standard method to give high-dose chemotherapy (CT). Proc Am Soc Clin Oncol 13:465","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1200\/JCO.1994.12.4.661","volume":"12","author":"G Spitzer","year":"1994","unstructured":"Spitzer G, Adkins DR, Spencer V, Dunphy FR, Petruska PJ, Velasquez WS, Bowers CE, Kronmueller N, Niemeyer R, McIntyre W (1994) Randomized study of growth factors postperipheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 12:661?670","journal-title":"J Clin Oncol"},{"key":"CR58","first-page":"232","volume":"12","author":"G Stoter","year":"1993","unstructured":"Stoter G, Sleijfer DT, Schornagel JH, ten Bokkel-Huinink WW, Vermeijlen K, Sylvester R on behalf of the EORTC Genito-Urinary Group (1993) BEP versus VIP in interme diate risk patients with disseminated non-seminomatous testicular caner (NSTC). Proc Am Soc Clin Oncol 12:232","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR59","first-page":"245","volume":"12","author":"S Tjulandin","year":"1993","unstructured":"Tjulandin S, Garin A, Stenina M, Mesherjakov N, Sidorova A, Sokolov N, Ljubimova N, Gutierrez F, Kupchan D, Graubner M (1993) Carboplatin (CBDA), etoposide (VP-16), bleomycin (B) and GM-CSF in patients (pts) with poor risk nonseminomatous germ cell tumours (NSGCT). Proc Am Soc Clin Oncol 12:245","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","volume":"316","author":"SD Williams","year":"1987","unstructured":"Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 316:1435?1440","journal-title":"N Engl J Med"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1200\/JCO.1984.2.4.271","volume":"4","author":"SN Wolff","year":"1984","unstructured":"Wolff SN, Johnson DH, Hainsworth JD, Greco FA (1984) High-dose VP-16-213 monotherapy for refractory germinal malignancies. A phase-II study. J Clin Oncol 4:271?274","journal-title":"J Clin Oncol"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1991.9.1.70","volume":"9","author":"AJ Wozniak","year":"1991","unstructured":"Wozniak AJ, Samson MK, Shah NT, Crawford ED, Ford CD, Altman SJ, Stephens RL, Natale RB, Bouroncle BA, Blumenstein BA, Cummings GD (1991) A randomized trial of cisplatin, vinblastine and bleomycin versus vinblastine, cisplatin and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group Study. J Clin Oncol 9:70?76","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00663009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00663009\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00663009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T11:53:01Z","timestamp":1586001181000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00663009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF00663009"],"URL":"https:\/\/doi.org\/10.1007\/bf00663009","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}